Vital Farms surges on earnings beat, $100M buyback
Ethical egg producer posts 18.4% EPS surprise and initiates share repurchase despite lowered 2026 guidance
Vital Farms shares climbed after the ethical egg producer reported fourth-quarter earnings that topped analyst expectations and authorized a $100 million stock repurchase program, signaling confidence despite moderating growth expectations for the coming year.
The Austin-based company delivered earnings per share of $0.35, beating the $0.30 consensus estimate by 18.4%. Revenue reached $213.6 million, exceeding the $191.3 million analyst target by 11.7%, according to the company's earnings release. The results capped a fiscal year in which the ethical food company achieved a significant profitability milestone, with adjusted EBITDA surpassing $100 million for the first time at $114 million.
Vital Farms reported full-year 2025 revenue of $759.4 million, representing 25.3% year-over-year growth. The strong performance reflects the company's expansion strategy within the ethical food category, where its pasture-raised eggs and free-range products have commanded premium prices despite broader inflationary pressures affecting traditional staples.
The board's authorization of a $100 million two-year stock repurchase program marks a significant milestone for the company, which has focused heavily on growth investment since going public. At the current market capitalization of approximately $1.2 billion, the buyback represents roughly 8% of shares outstanding, signaling management's belief that the stock remains undervalued following a sharp pullback from its 52-week high of $53.12.
However, the company tempered enthusiasm with guidance for fiscal 2026 that came in below expectations set during its investor day presentation. Management projected revenue of $900-920 million, representing 19-22% growth from 2025 levels. The lowered guidance reflects macro headwinds and challenges in maintaining the explosive growth rates that characterized earlier expansion phases.
Despite the moderated outlook, analyst sentiment remains overwhelmingly positive. The stock carries a consensus rating of buy, with 12 analysts recommending purchase and none suggesting hold or sell positions, according to market data. The average target price stands at $49.45, implying significant upside from current levels around $24.79.
The company's quarterly performance highlights a remarkable acceleration in growth, with earnings up 125% year-over-year and revenue increasing 37.2% compared to the prior-year period. Vital Farms' operating margin of 10.8% and return on equity of 20.7% demonstrate the company's ability to translate its premium positioning into meaningful profitability—a notable achievement in the highly competitive egg and dairy categories.
Vital Farms' business model, centered on animal welfare and sustainable farming practices, has resonated with consumers willing to pay premium prices for ethically sourced products. The company's "Ethically Raised" certification and network of family farms have become key differentiators in a marketplace increasingly focused on supply chain transparency and environmental impact.
The share repurchase announcement represents a strategic shift toward returning capital to shareholders alongside continued investment in the business. For a company that has historically prioritized rapid expansion and brand building, the buyback program suggests confidence in current cash flow generation and the maturity of its core business model.
Shares of Vital Farms have experienced significant volatility over the past year, trading as high as $53.12 and as low as $25.51. The current price of $24.79 reflects investor concerns about broader economic conditions and the sustainability of premium pricing in an inflation-sensitive consumer environment. The stock's current price-to-earnings ratio of 20.58 compares favorably to high-growth consumer staples peers, suggesting room for multiple expansion if execution remains strong.
Looking ahead, investors will focus on Vital Farms' ability to maintain pricing power amid potentially softer consumer spending while continuing to expand distribution and product offerings. The company's balance sheet health and ability to generate free cash flow for the new share repurchase program will be key metrics to monitor in the coming quarters.